Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells

Bibliographic Details
Main Author: Martins, Flávia
Publication Date: 2025
Other Authors: Machado, Ana L., Carvalho, Joana, Almeida, Catarina R., Beck, Hans C., Carvalho, Ana S., Backman, Vadim, Matthiesen, Rune, Velho, Sérgia
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10362/182833
Summary: Funding Information: The work was funded by internal grants (MSI and Cancer Challenge 2022) provided by the Institute for Molecular Pathology and Immunology of the University of Porto (IPATIMUP) and by national funds through FCT in the scope of the project 2022.05346.PTDC (https://doi.org/10.54499/2022.05346.PTDC). This article is also a result of the projects (iNOVA4Health\u2013UIDB/04462/2020 and UIDP/04462/2020, and by the Associated Laboratory LS4FUTURE (LA/P/0087/2020), two programs financially supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e Tecnologia / Minist\u00E9rio da Ci\u00EAncia, Tecnologia e Ensino Superior. FM is a Ph.D. student in the Doctoral Program in Biomedicine at the Faculty of Medicine of the University of Porto, and she is funded through a Ph.D. fellowship (SFRH/BD/143669/2019) awarded by the Portuguese Foundation for Science and Technology (FCT). ALM is a Ph.D. student in the Doctoral Program in Biomedicine from the Faculty of Medicine of the University of Porto, and she is funded through a Ph.D. fellowship (2020.08932.BD) awarded by the FCT. JC is hired by IPATIMUP under norma transit\u00F3ria do DL n.\u00B0 57/2016 alterada pela lei n.\u00B0 57/2017 (https://doi.org/10.54499/DL57/2016/CP1363/CT0012). CA was financially supported by national funds (OE), through Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia (FCT)/MCTES, within the scope of iBiMED\u2014Institute of Biomedicine (https://doi.org/10.54499/UIDP/04501/2020). ASC is supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia (https://doi.org/10.54499/DL57/2016/CP1457/CT0013). VB was supported by NIH grants R01CA228272, R02CA225002,\u00A0U54CA268084, and U54CA261694, NSF grant EFMA1830961, the Center for Physical Genomics and Engineering at Northwestern University, and philanthropic support from K. Hudson and R. Goldman, S. Brice and J. Esteve, M. E. Holliday and I. Schneider, the Christina Carinato Charitable Foundation, and D. Sachs. RM is supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia (CEEC position, https://doi.org/10.54499/CEECIND/03906/2017/CP1421/CT0004). SV is supported by FCT (https://doi.org/10.54499/2021.01550.CEECIND/CP1663/CT0012). Funding Information: The work was funded by internal grants (MSI and Cancer Challenge 2022) provided by the Institute for Molecular Pathology and Immunology of the University of Porto (IPATIMUP) and by national funds through FCT in the scope of the project 2022.05346.PTDC ( https://doi.org/10.54499/2022.05346.PTDC ). This article is also a result of the projects (iNOVA4Health\u2013UIDB/04462/2020 and UIDP/04462/2020, and by the Associated Laboratory LS4FUTURE (LA/P/0087/2020), two programs financially supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e Tecnologia / Minist\u00E9rio da Ci\u00EAncia, Tecnologia e Ensino Superior. FM is a Ph.D. student in the Doctoral Program in Biomedicine at the Faculty of Medicine of the University of Porto, and she is funded through a Ph.D. fellowship (SFRH/BD/143669/2019) awarded by the Portuguese Foundation for Science and Technology (FCT). ALM is a Ph.D. student in the Doctoral Program in Biomedicine from the Faculty of Medicine of the University of Porto, and she is funded through a Ph.D. fellowship (2020.08932.BD) awarded by the FCT. JC is hired by IPATIMUP under norma transit\u00F3ria do DL n.\u00B0 57/2016 alterada pela lei n.\u00B0 57/2017 ( https://doi.org/10.54499/DL57/2016/CP1363/CT0012 ). CA was financially supported by national funds (OE), through Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia (FCT)/MCTES, within the scope of iBiMED\u2014Institute of Biomedicine ( https://doi.org/10.54499/UIDP/04501/2020 ). ASC is supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia ( https://doi.org/10.54499/DL57/2016/CP1457/CT0013 ). VB was supported by NIH grants R01CA228272, R02CA225002, U54CA268084, and U54CA261694, NSF grant EFMA1830961, the Center for Physical Genomics and Engineering at Northwestern University, and philanthropic support from K. Hudson and R. Goldman, S. Brice and J. Esteve, M. E. Holliday and I. Schneider, the Christina Carinato Charitable Foundation, and D. Sachs. RM is supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia (CEEC position, https://doi.org/10.54499/CEECIND/03906/2017/CP1421/CT0004 ). SV is supported by FCT ( https://doi.org/10.54499/2021.01550.CEECIND/CP1663/CT0012 ). Funding Information: The authors acknowledge the support of Catarina Meireles and Emilia Cardoso from the Translational Cytometry unit (TraCy) i3S Scientific Platform. We acknowledge the COST Action CA20113 \u201CPROTEOCURE\u201D supported by COST (European Cooperation in Science and Technology). Publisher Copyright: © The Author(s) 2025.
id RCAP_431c06563c2dff24f85c3c19ce93f7cb
oai_identifier_str oai:run.unl.pt:10362/182833
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cellsGeneralSDG 3 - Good Health and Well-beingFunding Information: The work was funded by internal grants (MSI and Cancer Challenge 2022) provided by the Institute for Molecular Pathology and Immunology of the University of Porto (IPATIMUP) and by national funds through FCT in the scope of the project 2022.05346.PTDC (https://doi.org/10.54499/2022.05346.PTDC). This article is also a result of the projects (iNOVA4Health\u2013UIDB/04462/2020 and UIDP/04462/2020, and by the Associated Laboratory LS4FUTURE (LA/P/0087/2020), two programs financially supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e Tecnologia / Minist\u00E9rio da Ci\u00EAncia, Tecnologia e Ensino Superior. FM is a Ph.D. student in the Doctoral Program in Biomedicine at the Faculty of Medicine of the University of Porto, and she is funded through a Ph.D. fellowship (SFRH/BD/143669/2019) awarded by the Portuguese Foundation for Science and Technology (FCT). ALM is a Ph.D. student in the Doctoral Program in Biomedicine from the Faculty of Medicine of the University of Porto, and she is funded through a Ph.D. fellowship (2020.08932.BD) awarded by the FCT. JC is hired by IPATIMUP under norma transit\u00F3ria do DL n.\u00B0 57/2016 alterada pela lei n.\u00B0 57/2017 (https://doi.org/10.54499/DL57/2016/CP1363/CT0012). CA was financially supported by national funds (OE), through Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia (FCT)/MCTES, within the scope of iBiMED\u2014Institute of Biomedicine (https://doi.org/10.54499/UIDP/04501/2020). ASC is supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia (https://doi.org/10.54499/DL57/2016/CP1457/CT0013). VB was supported by NIH grants R01CA228272, R02CA225002,\u00A0U54CA268084, and U54CA261694, NSF grant EFMA1830961, the Center for Physical Genomics and Engineering at Northwestern University, and philanthropic support from K. Hudson and R. Goldman, S. Brice and J. Esteve, M. E. Holliday and I. Schneider, the Christina Carinato Charitable Foundation, and D. Sachs. RM is supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia (CEEC position, https://doi.org/10.54499/CEECIND/03906/2017/CP1421/CT0004). SV is supported by FCT (https://doi.org/10.54499/2021.01550.CEECIND/CP1663/CT0012). Funding Information: The work was funded by internal grants (MSI and Cancer Challenge 2022) provided by the Institute for Molecular Pathology and Immunology of the University of Porto (IPATIMUP) and by national funds through FCT in the scope of the project 2022.05346.PTDC ( https://doi.org/10.54499/2022.05346.PTDC ). This article is also a result of the projects (iNOVA4Health\u2013UIDB/04462/2020 and UIDP/04462/2020, and by the Associated Laboratory LS4FUTURE (LA/P/0087/2020), two programs financially supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e Tecnologia / Minist\u00E9rio da Ci\u00EAncia, Tecnologia e Ensino Superior. FM is a Ph.D. student in the Doctoral Program in Biomedicine at the Faculty of Medicine of the University of Porto, and she is funded through a Ph.D. fellowship (SFRH/BD/143669/2019) awarded by the Portuguese Foundation for Science and Technology (FCT). ALM is a Ph.D. student in the Doctoral Program in Biomedicine from the Faculty of Medicine of the University of Porto, and she is funded through a Ph.D. fellowship (2020.08932.BD) awarded by the FCT. JC is hired by IPATIMUP under norma transit\u00F3ria do DL n.\u00B0 57/2016 alterada pela lei n.\u00B0 57/2017 ( https://doi.org/10.54499/DL57/2016/CP1363/CT0012 ). CA was financially supported by national funds (OE), through Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia (FCT)/MCTES, within the scope of iBiMED\u2014Institute of Biomedicine ( https://doi.org/10.54499/UIDP/04501/2020 ). ASC is supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia ( https://doi.org/10.54499/DL57/2016/CP1457/CT0013 ). VB was supported by NIH grants R01CA228272, R02CA225002, U54CA268084, and U54CA261694, NSF grant EFMA1830961, the Center for Physical Genomics and Engineering at Northwestern University, and philanthropic support from K. Hudson and R. Goldman, S. Brice and J. Esteve, M. E. Holliday and I. Schneider, the Christina Carinato Charitable Foundation, and D. Sachs. RM is supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia (CEEC position, https://doi.org/10.54499/CEECIND/03906/2017/CP1421/CT0004 ). SV is supported by FCT ( https://doi.org/10.54499/2021.01550.CEECIND/CP1663/CT0012 ). Funding Information: The authors acknowledge the support of Catarina Meireles and Emilia Cardoso from the Translational Cytometry unit (TraCy) i3S Scientific Platform. We acknowledge the COST Action CA20113 \u201CPROTEOCURE\u201D supported by COST (European Cooperation in Science and Technology). Publisher Copyright: © The Author(s) 2025.Despite the development of mutant-selective KRAS inhibitors, colorectal cancer (CRC) responses remain limited, with stable disease and rapid recurrence being common outcomes. The molecular mechanisms enabling CRC cells to tolerate KRAS inhibition and ultimately develop resistance remain poorly understood. Here, we investigated early transcriptional and proteomic responses to KRAS silencing in 3D CRC cell line spheroid models, aiming to identify pathways associated with sensitivity or resistance to KRAS blockade. Cell lines were stratified into KRAS silencing-sensitive (HCT116 and SW480) and -resistant (LS174T and SW837) groups based on spheroid growth, cell cycle progression, and apoptosis induction. Transcriptional profiling revealed the unfolded protein response (UPR) and WNT/β-catenin signaling as pathways specifically upregulated in KRAS silencing-sensitive cells and downregulated in resistant cells. Proteomic analysis of membrane-enriched fractions further supported UPR deregulation, showing a pronounced downregulation of translation-related proteins in sensitive cells. Functional assays validated that the sensitive cell line HCT116 exhibits reduced protein aggregation and lower translational capacity upon KRAS knockdown, consistent with UPR activation. Pharmacological inhibition of IRE1α-mediated UPR signaling did not revert KRAS silencing-induced cell cycle arrest or apoptosis in this cell line. Collectively, our results highlight the UPR activation as an early adaptive response of KRAS-dependent CRC cells to KRAS silencing.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)iNOVA4Health - pólo NMSRUNMartins, FláviaMachado, Ana L.Carvalho, JoanaAlmeida, Catarina R.Beck, Hans C.Carvalho, Ana S.Backman, VadimMatthiesen, RuneVelho, Sérgia2025-05-07T21:35:28Z2025-042025-04-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/182833eng2045-2322PURE: 115798878https://doi.org/10.1038/s41598-025-94549-2info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-05-19T01:40:11Zoai:run.unl.pt:10362/182833Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-29T07:14:11.810748Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells
title Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells
spellingShingle Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells
Martins, Flávia
General
SDG 3 - Good Health and Well-being
title_short Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells
title_full Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells
title_fullStr Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells
title_full_unstemmed Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells
title_sort Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells
author Martins, Flávia
author_facet Martins, Flávia
Machado, Ana L.
Carvalho, Joana
Almeida, Catarina R.
Beck, Hans C.
Carvalho, Ana S.
Backman, Vadim
Matthiesen, Rune
Velho, Sérgia
author_role author
author2 Machado, Ana L.
Carvalho, Joana
Almeida, Catarina R.
Beck, Hans C.
Carvalho, Ana S.
Backman, Vadim
Matthiesen, Rune
Velho, Sérgia
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
iNOVA4Health - pólo NMS
RUN
dc.contributor.author.fl_str_mv Martins, Flávia
Machado, Ana L.
Carvalho, Joana
Almeida, Catarina R.
Beck, Hans C.
Carvalho, Ana S.
Backman, Vadim
Matthiesen, Rune
Velho, Sérgia
dc.subject.por.fl_str_mv General
SDG 3 - Good Health and Well-being
topic General
SDG 3 - Good Health and Well-being
description Funding Information: The work was funded by internal grants (MSI and Cancer Challenge 2022) provided by the Institute for Molecular Pathology and Immunology of the University of Porto (IPATIMUP) and by national funds through FCT in the scope of the project 2022.05346.PTDC (https://doi.org/10.54499/2022.05346.PTDC). This article is also a result of the projects (iNOVA4Health\u2013UIDB/04462/2020 and UIDP/04462/2020, and by the Associated Laboratory LS4FUTURE (LA/P/0087/2020), two programs financially supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e Tecnologia / Minist\u00E9rio da Ci\u00EAncia, Tecnologia e Ensino Superior. FM is a Ph.D. student in the Doctoral Program in Biomedicine at the Faculty of Medicine of the University of Porto, and she is funded through a Ph.D. fellowship (SFRH/BD/143669/2019) awarded by the Portuguese Foundation for Science and Technology (FCT). ALM is a Ph.D. student in the Doctoral Program in Biomedicine from the Faculty of Medicine of the University of Porto, and she is funded through a Ph.D. fellowship (2020.08932.BD) awarded by the FCT. JC is hired by IPATIMUP under norma transit\u00F3ria do DL n.\u00B0 57/2016 alterada pela lei n.\u00B0 57/2017 (https://doi.org/10.54499/DL57/2016/CP1363/CT0012). CA was financially supported by national funds (OE), through Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia (FCT)/MCTES, within the scope of iBiMED\u2014Institute of Biomedicine (https://doi.org/10.54499/UIDP/04501/2020). ASC is supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia (https://doi.org/10.54499/DL57/2016/CP1457/CT0013). VB was supported by NIH grants R01CA228272, R02CA225002,\u00A0U54CA268084, and U54CA261694, NSF grant EFMA1830961, the Center for Physical Genomics and Engineering at Northwestern University, and philanthropic support from K. Hudson and R. Goldman, S. Brice and J. Esteve, M. E. Holliday and I. Schneider, the Christina Carinato Charitable Foundation, and D. Sachs. RM is supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia (CEEC position, https://doi.org/10.54499/CEECIND/03906/2017/CP1421/CT0004). SV is supported by FCT (https://doi.org/10.54499/2021.01550.CEECIND/CP1663/CT0012). Funding Information: The work was funded by internal grants (MSI and Cancer Challenge 2022) provided by the Institute for Molecular Pathology and Immunology of the University of Porto (IPATIMUP) and by national funds through FCT in the scope of the project 2022.05346.PTDC ( https://doi.org/10.54499/2022.05346.PTDC ). This article is also a result of the projects (iNOVA4Health\u2013UIDB/04462/2020 and UIDP/04462/2020, and by the Associated Laboratory LS4FUTURE (LA/P/0087/2020), two programs financially supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e Tecnologia / Minist\u00E9rio da Ci\u00EAncia, Tecnologia e Ensino Superior. FM is a Ph.D. student in the Doctoral Program in Biomedicine at the Faculty of Medicine of the University of Porto, and she is funded through a Ph.D. fellowship (SFRH/BD/143669/2019) awarded by the Portuguese Foundation for Science and Technology (FCT). ALM is a Ph.D. student in the Doctoral Program in Biomedicine from the Faculty of Medicine of the University of Porto, and she is funded through a Ph.D. fellowship (2020.08932.BD) awarded by the FCT. JC is hired by IPATIMUP under norma transit\u00F3ria do DL n.\u00B0 57/2016 alterada pela lei n.\u00B0 57/2017 ( https://doi.org/10.54499/DL57/2016/CP1363/CT0012 ). CA was financially supported by national funds (OE), through Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia (FCT)/MCTES, within the scope of iBiMED\u2014Institute of Biomedicine ( https://doi.org/10.54499/UIDP/04501/2020 ). ASC is supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia ( https://doi.org/10.54499/DL57/2016/CP1457/CT0013 ). VB was supported by NIH grants R01CA228272, R02CA225002, U54CA268084, and U54CA261694, NSF grant EFMA1830961, the Center for Physical Genomics and Engineering at Northwestern University, and philanthropic support from K. Hudson and R. Goldman, S. Brice and J. Esteve, M. E. Holliday and I. Schneider, the Christina Carinato Charitable Foundation, and D. Sachs. RM is supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia (CEEC position, https://doi.org/10.54499/CEECIND/03906/2017/CP1421/CT0004 ). SV is supported by FCT ( https://doi.org/10.54499/2021.01550.CEECIND/CP1663/CT0012 ). Funding Information: The authors acknowledge the support of Catarina Meireles and Emilia Cardoso from the Translational Cytometry unit (TraCy) i3S Scientific Platform. We acknowledge the COST Action CA20113 \u201CPROTEOCURE\u201D supported by COST (European Cooperation in Science and Technology). Publisher Copyright: © The Author(s) 2025.
publishDate 2025
dc.date.none.fl_str_mv 2025-05-07T21:35:28Z
2025-04
2025-04-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/182833
url http://hdl.handle.net/10362/182833
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2045-2322
PURE: 115798878
https://doi.org/10.1038/s41598-025-94549-2
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833602925627179008